BeiGene

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$1,498,170
$1,412,284
$1,315,300
$1,117,279
Gross Profit
1,355,748
1,215,774
1,150,694
952,277
EBITDA
417,579
163,114
123,499
43,906
EBIT
207,475
147,164
87,885
11,102
Net Income
66,502
124,841
94,320
1,270
Net Change In Cash
1,498,170
1,412,284
1,315,300
1,117,279
Free Cash Flow
131,275
354,469
199,772
-72,325
Cash
4,547,530
4,036,868
2,756,056
2,516,411
Basic Shares
113,448
114,519
112,846
111,173

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$5,343,033
$3,810,241
$2,458,779
$1,415,921
Gross Profit
4,674,493
3,216,152
2,078,859
1,129,446
EBITDA
616,774
-396,437
-1,120,061
-1,723,387
EBIT
475,088
-568,199
-1,207,736
-1,789,665
Net Income
286,933
-644,786
-881,708
-2,003,815
Net Change In Cash
5,343,033
3,810,241
2,458,779
1,415,921
Free Cash Flow
941,741
-669,768
-1,753,714
-1,965,718
Cash
4,547,530
2,627,410
3,171,800
3,869,564
Basic Shares
113,448
105,288
104,387
103,133

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$0.58
2025-09-30
$2.65
2025-06-30
$0.91